Literature DB >> 15941769

Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway.

Maija Hirsilä1, Peppi Koivunen, Leon Xu, Todd Seeley, Kari I Kivirikko, Johanna Myllyharju.   

Abstract

Hypoxia-inducible transcription factor (HIF) is regulated by two oxygen-dependent events that are catalyzed by the HIF prolyl 4-hydroxylases (HIF-P4Hs) and HIF asparaginyl hydroxylase (FIH). We have purified the three recombinant human HIF-P4Hs to near homogeneity and characterized their catalytic properties and inhibition and those of FIH. The specific activities of the HIF-P4Hs were at least 40-50 mol/mol/min, and they and FIH catalyzed an uncoupled decarboxylation of 2-oxoglutarate in the absence of any peptide substrate. The purified HIF-P4Hs showed considerable activities even without added Fe2+, their apparent Km values for iron being markedly lower than that of FIH. Desferrioxamine and several metals were effective inhibitors of FIH, but surprisingly, ineffective inhibitors of the HIF-P4Hs in vitro, especially of HIF-P4H-2. Desferrioxamine and cobalt were more effective in cultured insect cells synthesizing recombinant HIF-P4H-2, but complete inhibition was not achieved and most of the enzyme was inactivated irreversibly. Cobalt also rapidly inactivated HIF-P4Hs during storage at 4 degrees C. The well-known stabilization of HIF-alpha by cobalt and nickel is thus not due to a simple competitive inhibition of HIF-P4Hs. The effective inhibition of FIH by these metals and zinc probably leads to full transcriptional activity of HIF-alpha even in concentrations that produce no stabilization of HIF-alpha.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941769     DOI: 10.1096/fj.04-3399fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

Review 2.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

3.  Estrogen-related receptor gamma (ERRgamma) mediates oxygen-dependent induction of aromatase (CYP19) gene expression during human trophoblast differentiation.

Authors:  Premlata Kumar; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2011-07-14

Review 4.  Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

Review 6.  The TET enzymes.

Authors:  Peppi Koivunen; Tuomas Laukka
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

Review 7.  Texaphyrins: tumor localizing redox active expanded porphyrins.

Authors:  Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

Review 8.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

9.  Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.

Authors:  Mohammad H Pourgholami; Zhao Y Cai; Samina Badar; Kiran Wangoo; Marianne S Poruchynsky; David L Morris
Journal:  BMC Cancer       Date:  2010-04-15       Impact factor: 4.430

10.  A dialogue between the hypoxia-inducible factor and the tumor microenvironment.

Authors:  Frédéric Dayan; Nathalie M Mazure; M Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Cancer Microenviron       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.